XML 54 R42.htm IDEA: XBRL DOCUMENT v3.4.0.3
Net Loss Per Share (Details) - USD ($)
3 Months Ended
Mar. 31, 2016
Mar. 31, 2015
Numerator    
Net loss attributable to Inovio Pharmaceuticals, Inc. $ (8,042,820) $ (10,581,779)
Reflect adjustment for decrease in fair value of warrant liability 0 (289,773)
Numerator for use in diluted loss per share $ (8,042,820) $ (10,871,552)
Denominator    
Weighted average number of common shares outstanding (shares) 72,230,411 60,741,082
Effect of dilutive potential common shares from warrants (shares) 0 172,341
Denominator for use in diluted loss per share (shares) 72,230,411 60,913,423
Net loss per share, diluted ($ per share) $ (0.11) $ (0.18)
Antidilutive securities excluded from computation of earnings per share, amount (shares) 8,437,652 6,797,192
Options to purchase commons stock [Member]    
Denominator    
Antidilutive securities excluded from computation of earnings per share, amount (shares) 7,135,624 5,930,767
Warrants to purchase common stock [Member]    
Denominator    
Antidilutive securities excluded from computation of earnings per share, amount (shares) 560,904 727,969
Restricted stock units [Member]    
Denominator    
Antidilutive securities excluded from computation of earnings per share, amount (shares) 732,668 130,000
Convertible preferred stock [Member]    
Denominator    
Antidilutive securities excluded from computation of earnings per share, amount (shares) 8,456 8,456